Data / Research funding / California / Doheny Eye Institute
Doheny Eye Institute: 14 NIH awards ($15.8M), fiscal years 2021 to 2026
Doheny Eye Institute in Pasadena, CA is funded under 14 NIH awards ($15.8M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- YM8RKEGJ5UN1
- State
- California
Awards
14 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Mitochondrial defects in the retinal pigment epithelium and the CFH risk allele for age-related macular degeneration | NIH | National Eye Institute | 2022 to 2025 | $2,526,222 | April 1, 2018 | June 30, 2026 | FERRINGTON, DEBORAH ANN | reporter.nih.gov |
| Epidemiology of Biomarkers of AMD Progression | NIH | National Eye Institute | 2021 to 2025 | $2,396,992 | September 30, 2021 | August 31, 2027 | SADDA, SRINIVAS R | reporter.nih.gov |
| In Vivo Characterizations of Retinal Hemodynamics | NIH | National Eye Institute | 2022 to 2025 | $1,544,333 | September 30, 2022 | July 31, 2027 | ZHANG, YUHUA LIANG | reporter.nih.gov |
| Mechanobiology of Retinal Vascular Inflammation and Degeneration in Diabetes | NIH | National Eye Institute | 2025 | $1,523,433 | September 1, 2025 | August 31, 2028 | GHOSH, KAUSTABH | reporter.nih.gov |
| Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU) | NIH | National Eye Institute | 2021 to 2023 | $1,387,547 | September 1, 2009 | December 31, 2024 | SUN, DEMING | reporter.nih.gov |
| Retinal Ganglion Cell Signaling Regulated By Intrinsic Reactive Oxygen Species | NIH | National Eye Institute | 2023 to 2025 | $1,177,500 | August 1, 2023 | March 31, 2028 | BARNES, STEVEN ANDREW | reporter.nih.gov |
| Deciphering the mechanisms associated with high-risk AMD genotypes for ARMS2/HTRA1 andComplement Factor H | NIH | National Eye Institute | 2022 to 2024 | $1,174,621 | September 30, 2022 | August 31, 2025 | FERRINGTON, DEBORAH ANN | reporter.nih.gov |
| Novel Mechanisms of Subretinal Fibrosis in Age-related Macular Degeneration | NIH | National Eye Institute | 2021 to 2023 | $1,068,436 | May 1, 2020 | April 30, 2025 | KANNAN, RAM | reporter.nih.gov |
| In vivo Imaging of the Human Retina at the Molecular Level | NIH | National Eye Institute | 2024 to 2025 | $1,047,218 | March 1, 2024 | February 29, 2028 | SADDA, SRINIVAS R | reporter.nih.gov |
| In vivo Ultrastructure of Chorioretinal Disease | NIH | National Eye Institute | 2021 to 2023 | $1,033,059 | January 1, 2015 | August 31, 2025 | ZHANG, YUHUA LIANG | reporter.nih.gov |
| Role of Retinal Capillary Stiffness in Diabetic Retinopathy | NIH | National Eye Institute | 2021 | $377,419 | September 1, 2017 | June 30, 2023 | GHOSH, KAUSTABH | reporter.nih.gov |
| Retina-derived extracellular vesicles in diabetic retinopathy: their potential role in pathogenesis and therapy | NIH | National Eye Institute | 2025 | $249,000 | June 1, 2023 | August 31, 2028 | LESSIEUR, EMMA M | reporter.nih.gov |
| Artificial Intelligence for Assessment of Stargardt Macular Atrophy | NIH | National Eye Institute | 2021 | $190,362 | January 1, 2020 | December 31, 2023 | HU, ZHIHONG | reporter.nih.gov |
| Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye | NIH | National Eye Institute | 2021 | $148,054 | May 1, 2020 | September 30, 2021 | HUANG, ALEX | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 7 | $4,267,019 | 0 | $0 |
| 2024 | 6 | $2,885,933 | 0 | $0 |
| 2023 | 8 | $3,553,508 | 0 | $0 |
| 2022 | 6 | $2,631,727 | 0 | $0 |
| 2021 | 7 | $2,506,009 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Eye Disease and Disorders of Vision
- Neurosciences
- Neurodegenerative
- Macular Degeneration
- Aging
- Biomedical Imaging
- Bioengineering
- Clinical Research
- Diabetes
- Prevention
- Genetics
- Cardiovascular
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.